Home > Insider Trading > Filing (0001179110-19-001173)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800	Abbott Laboratories	ABT	Pharmaceutical Preparations (2834)	360698440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1587070	Jaime Contreras	100 Abbott Park Road Abbott Park IL 60064	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares Without Par Value	Acquisiton	2019-01-30	46,017	$44.40	100,985	No	4	M	Direct
Common Shares Without Par Value	Acquisiton	2019-01-30	84,169	$38.40	185,154	No	4	M	Direct
Common Shares Without Par Value	Acquisiton	2019-01-30	83,951	$47.00	269,105	No	4	M	Direct
Common Shares Without Par Value	Disposition	2019-01-30	177,457	$70.00	91,648	No	4	S	Direct
Common Shares Without Par Value	Acquisiton	2019-01-31	62,600	$47.00	154,248	No	4	M	Direct
Common Shares Without Par Value	Acquisiton	2019-01-31	77,550	$38.40	231,798	No	4	M	Direct
Common Shares Without Par Value	Disposition	2019-01-31	108,090	$71.68	111,301	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Option (right to buy)	Disposition	2019-01-30	46,017	$0.00	46,017	$44.40
Common Shares	Option (right to buy)	Disposition	2019-01-30	84,169	$0.00	84,169	$38.40
Common Shares	Option (right to buy)	Disposition	2019-01-30	83,951	$0.00	83,951	$47.00
Common Shares	Option (right to buy)	Disposition	2019-01-31	62,600	$0.00	62,600	$47.00
Common Shares	Option (right to buy)	Disposition	2019-01-31	77,550	$0.00	77,550	$38.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
92,032	2018-02-17	2027-02-16	No	4	M	Direct
158,410	2017-02-19	2026-02-18	No	4	M	Direct
62,600	2016-02-20	2025-02-19	No	4	M	Direct
0	2018-02-20	2025-02-19	No	4	M	Direct
80,860	2018-02-19	2026-02-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares Without Par Value	22	Indirect	Profit Sharing Trust
Common Shares Without Par Value	84,579	Indirect	Jaime Contreras Marvan 2006 Living Trust
Common Shares Without Par Value	2,595	Indirect	By Spouse
Common Shares Without Par Value	12,081	Indirect	Living Trust (by spouse)

Footnotes

Excludes 12,407 shares previously directly owned which were transferred to the Jaime Contreras Marvan 2006 Living Trust on September 21, 2018.
Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2019.
Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
The reporting person disclaims beneficial ownership of all securities held by his spouse.
Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.